Profilo
David N.
Bell worked as the Chief Scientific Officer & VP-Drug Development at Therapure Biopharma, Inc. from 2007 to 2020.
Prior to that, he was the Vice President-Drug Development & Research at 1608557 Ontario, Inc. He received a graduate degree from McGill University and a doctorate in 1988 from the same institution.
Precedenti posizioni note di David N. Bell
| Società | Posizione | Fine |
|---|---|---|
Therapure Biopharma, Inc.
 Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Direttore Tecnico/Scientifico/R&S | 01/01/2020 |
1608557 Ontario, Inc.
 1608557 Ontario, Inc. BiotechnologyHealth Technology 1608557 Ontario, Inc. develops and manufacturers biologics, particularly blood-related based therapeutics. The company was founded in 1985 and is headquartered in Mississauga, Canada. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di David N. Bell
| McGill University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
1608557 Ontario, Inc.
1608557 Ontario, Inc. BiotechnologyHealth Technology 1608557 Ontario, Inc. develops and manufacturers biologics, particularly blood-related based therapeutics. The company was founded in 1985 and is headquartered in Mississauga, Canada. | Health Technology |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- David N. Bell
